Fresenius Kabi Morphine Sulfate prefilled syringes recalled for labeling mix-up with wrong opioid
Fresenius Kabi Morphine syringes recalled for wrong opioid in packaging
Fresenius Kabi recalled one lot of Morphine Sulfate Injection 2 mg/1 mL prefilled syringes due to a labeling error. Packages labeled as morphine may actually contain Dilaudid (hydromorphone), a different and more potent opioid. Using the wrong medication could cause serious respiratory problems or death, especially in patients not used to opioids or those with lung disease.
- If you work in a healthcare facility, immediately stop using and distributing lot 6402820 (expiration 12/2028).
- Return all units of this lot to Fresenius Kabi.
- Contact Fresenius Kabi at 1-866-716-2459 (Monday–Friday, 8 a.m.–5 p.m. CST) if you have questions.
- If a patient received this product, contact a physician or healthcare provider right away.
Product photos
FOR IMMEDIATE RELEASE – 8/4/2026 – LAKE ZURICH, Ill.— Fresenius Kabi, an operating company of the Fresenius Group, is voluntarily recalling one lot of Morphine Sulfate Injection USP, Simplist® 2 mg/1 mL due to a label mix-up. The MicroVault labeled as Morphine 2 mg/1 mL, may contain a Prefilled Syri
Official notice
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/fresenius-kabi-issues-voluntary-nationwide-recall-one-lot-morphine-sulfate-injection-usp-simplistrDon't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief
